Detection of GABHS in Throat Gargle

NCT03231098 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2019-12-10

No results posted yet for this study

Summary

The objective of this study is to investigate the use of patient throat gargle as an alternative to throat swabbing for the diagnosis of pharyngitis caused by Group A β-Hemolytic Streptococcus (GABHS) infection, also known as strep throat.

Conditions

  • Group A Streptococcus: B Hemolytic Pharyngitis

Sponsors & Collaborators

  • Gargle Tech

    lead INDUSTRY

Principal Investigators

  • Avraham Alpert, MD · Shaare Zedek Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-12
Primary Completion
2019-02-16
Completion
2019-02-16

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03231098 on ClinicalTrials.gov